RTI Surgical collaborates with ADA on report for tracking and tracing of human tissue-based products
The report defines inventory management requirements in dental practices for HCT/Ps to ensure traceability from the donor to the recipient and the recipient to the donor
HCT/Ps are used in more than a million medical and dental procedures per year, including bone and gum grafting and repair
Last week, RTI Surgical Inc. (Alachua, Florida; Nasdaq: RTIX) issued a statement regarding its collaboration with the American Dental Association (ADA) on a new report regarding tissue implants used in dental surgeries. The report aims to improve the tracking and tracing of tissue implants in dentistry.
Technical Report (TR) 1089, Track and Trace for Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps), defines inventory management requirements in dental practices for HCT/Ps to ensure traceability from the donor to the recipient and the recipient to the donor. Its intent is also to facilitate reporting of potential adverse reactions to all parties involved in processing the HCT/P.
The report may be found on the ADA website here. It is free to ADA members and may be purchased by non-ADA members for $39.
RTI Surgical Inc. (RTI) is a global surgical implant company that provides surgeons with biologic, metal, and synthetic implants. According to RTI, HCT/Ps are used in more than a million medical and dental procedures per year, including bone and gum grafting and repair, among many others. Most of these services are routinely performed in dental practices, hospitals, ambulatory surgery centers (ASC) and other medical facilities.
While requirements exist for tissue banks and many health-care facilities to have validated processes in place to track and trace HCT/Ps, there is a lack of appropriate standardized identification standards and a mechanism by which to collect, store and share HCT/P data for public health, clinical and research purposes. Not only can this data be useful for public health, clinical purposes, and research purposes, it can also improve tissue banks’ efforts to connect donor families with recipients.
“RTI has been working diligently, both individually and with the tissue-banking community, to enhance and extend the requirements for standardized tracking and tracing of these important tissue implants. Making these important connections enhances donation and tissue transplantation,” said Brian K. Hutchison, RTI president and CEO. “We anticipate TR 1089 will have far-reaching impact, given its applicability to other health care settings.”
Source: RTI Surgical press release 5 October 2016
This article first appeared in the Apex360 e-newsletter. Apex360 is a DentistryIQ partner publication for dental practitioners and members of the dental industry. Its goal is to provide timely dental information and present it in meaningful context, empowering those in the dental space to make better business decisions. Visit the Apex360 home page here, and subscribe to the Apex360 e-newsletter here.